Mazyar Shadman, Philip Thompson, Benjamin Heyman, Martin Hutchings, Leslie A. Lori, Junichiro Yuda, Pier Luigi Zinzani, Dachelle Colton, Daniela Hoehn, Macarena Izuzquiza, Anthony Mato, Gullu Gorgun, Robert W. Chen, John Kuruvilla. "TITANium: An open-label, global multicenter phase 1/2 study of AZD5492, a first-in-class subcutaneous CD8-guided tri-specific T-cell engager (TCE), in patients (pts) with relapsed or refractory (r/r) B-cell malignancies.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.tps7091